MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Net loss-$569K (73.91%↑ Y/Y)Income fromdiscontinued operations, net...$84K (-35.88%↓ Y/Y)Net loss fromcontinuing operations-$653K (71.76%↑ Y/Y)Sublease income$1,847K Miscellaneous income$1,748K (-27.68%↓ Y/Y)Interest income, net$142K Loss from continuingoperations before income...-$653K (72.13%↑ Y/Y)Total other income$3,737K (54.61%↑ Y/Y)Us$1,792K (59.57%↑ Y/Y)Non Us$1,230K (92.79%↑ Y/Y)Loss from operations-$4,390K (7.77%↑ Y/Y)License revenue$3,022K (71.61%↑ Y/Y)Total operatingexpenses$7,412K (13.66%↑ Y/Y)General andadministrative$6,852K (10606.25%↑ Y/Y)Depreciation & amortization$384K (-24.56%↓ Y/Y)Write-off and impairmentof patents$176K
Income Statement
source: myfinsight.com

TherapeuticsMD, Inc. (TXMD)

TherapeuticsMD, Inc. (TXMD)